Current News Interface Biosciences has secured $3 million in an oversubscribed seed funding round to advance its AI drug discovery platform for inflammatory disease Posted on December 14, 2023December 14, 2023 by Cort Meyerson 14 Dec Cort Meyerson Turion Space was selected for the NRO’s Strategic Commercial Enhancements program. C2i Genomics (Life Sciences, 19-20 Cohort) will be acquired by Veracyte for up to $95M